640 results on '"Kullberg, Bart-Jan"'
Search Results
2. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications
3. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study
4. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
5. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
6. Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections
7. P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data
8. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
9. Towards personalized medicine: a scoping review of immunotherapy in sepsis.
10. Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study
11. Correction to “Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study”
12. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
13. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis
14. Human TLR10 is an anti-inflammatory pattern-recognition receptor
15. Identifying platelet-derived factors as amplifiers ofB. burgdorferi-induced cytokine production
16. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital
17. Concerns about the external validity of the study ‘prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study’-authors´ reply
18. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12
19. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
20. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
21. Genetic Variation in the Dectin-1/CARD9 Recognition Pathway and Susceptibility to Candidemia
22. Ocular Manifestations of Candidemia
23. Reply to Kontoyiannis
24. The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
25. 1,25-dihydroxyvitamin D₃ Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses
26. Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
27. Recognition of Borrelia burgdorferi by NOD2 Is Central for the Induction of an Inflammatory Reaction
28. Reactive Oxygen Species-Independent Activation of the IL-1β Inflammasome in Cells from Patients with Chronic Granulomatous Disease
29. Early Stop Polymorphism in Human DECTIN-1 Is Associated with Increased Candida Colonization in Hematopoietic Stem Cell Transplant Recipients
30. Reply to Kontoyiannis
31. Functional and Genetic Evidence That the Mal/TIRAP Allele Variant 180L Has Been Selected by Providing Protection against Septic Shock
32. Bypassing Pathogen-Induced Inflammasome Activation for the Regulation of Interleukin-1β Production by the Fungal Pathogen Candida albicans
33. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
34. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
35. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
36. Immune Recognition of Candida albicans β-Glucan by Dectin-1
37. TLR4 Polymorphisms, Infectious Diseases, and Evolutionary Pressure during Migration of Modern Humans
38. Effect of Optimized Antibiotic Prophylaxis on the Incidence of Surgical Site Infection
39. Endogenous Interleukin (IL)-1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis
40. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.
41. C[X.sub.3]CR1-dependent renal macrophage survival promotes Candida control and host survival
42. Recombinant Interleukin-18 Protects against Disseminated Candida Albicans Infection in Mice
43. The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
44. Aspergillus fumigatus Evades Immune Recognition during Germination through Loss of Toll-Like Receptor-4-Mediated Signal Transduction
45. Delayed Clearance of Intraabdominal Abscesses Caused by Candida albicans in Tumor Necrosis Factor-α- and Lymphotoxin-a-Deficient Mice
46. Reply
47. The Role of Toll-like Receptor (TLR) 2 and TLR4 in the Host Defense against Disseminated Candidiasis
48. The Role of Endogenous Interleukin (IL)-18, IL-12, IL-1β, and Tumor Necrosis Factor-α in the Production of Interferon-γ Induced by Candida albicans in Human Whole-Blood Cultures
49. Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study
50. Role of Fas/FasL in Systemic Candidiasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.